0002111997-26-000001.txt : 20260218 0002111997-26-000001.hdr.sgml : 20260218 20260218165450 ACCESSION NUMBER: 0002111997-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260218 DATE AS OF CHANGE: 20260218 EFFECTIVENESS DATE: 20260218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Verra Therapeutics, Inc. CENTRAL INDEX KEY: 0002111997 ORGANIZATION NAME: EIN: 332257322 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573922 FILM NUMBER: 26649634 BUSINESS ADDRESS: STREET 1: 1939 EAST SHORE DR. SUITE 5 CITY: LANSING STATE: NY ZIP: 14882 BUSINESS PHONE: 607 227 6828 MAIL ADDRESS: STREET 1: 1939 EAST SHORE DR. SUITE 5 CITY: LANSING STATE: NY ZIP: 14882 D 1 primary_doc.xml X0708 D LIVE 0002111997 Verra Therapeutics, Inc. 1939 EAST SHORE DR. SUITE 5 LANSING NY NEW YORK 14882 607 227 6828 DELAWARE None None Corporation true 2024 Christopher Lucas Prince 1939 East Shore Dr. Suite 5 Lansing NY NEW YORK 14882 Director President Christopher Lucas Prince 1939 East Shore Dr. Suite 5 Lansing NY NEW YORK 14882 Executive Officer Chief Executive Officer Christopher Lucas Prince 1939 East Shore Dr. Suite 5 Lansing NY NEW YORK 14882 Director Secretary Jeffrey Calkins 1939 East Shore Dr. Suite 5 Lansing NY NEW YORK 14882 Director Treasurer Biotechnology $1 - $1,000,000 06b false 2024-12-16 true true false 10000 450000 205000 245000 false 6 0 0 0 false Verra Therapeutics, Inc. Christopher Lucas Prince Christopher Lucas Prince Chief Executive Officer 2026-02-18